風邪・インフルエンザサプリメントの世界市場2020-2027:市場規模、シェア、動向分析

Grand View Researchが発行した調査報告書(GV20JN196)
◆英語タイトル:Cold And Flu Supplements Market Size, Share & Trends Analysis Report By Product (Natural Molecules, Herbal Extracts, Vitamins & Minerals), By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN196
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年5月
◆ページ数:80
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2週間)
◆調査対象地域:クローバル
◆産業分野:食品・飲料
◆販売価格オプション(消費税別)
Single UserUSD2,450 ⇒換算¥262,150見積依頼/購入/質問フォーム
Multi User/Five UserUSD3,450 ⇒換算¥369,150見積依頼/購入/質問フォーム
Global/corporate LicenseUSD5,450 ⇒換算¥583,150見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、風邪・インフルエンザサプリメントの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、消費者行動分析、製品別(天然分子、ハーブ抽出物、ビタミン、ミネラル)分析、地域別分析、競争分析、企業情報など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・消費者行動分析
・風邪・インフルエンザサプリメントの世界市場規模:製品別(天然分子、ハーブ抽出物、ビタミン、ミネラル)
・風邪・インフルエンザサプリメントの世界市場規模:地域別
・競争分析
・企業情報
【レポートの概要】

Cold & Flu Supplements Market Growth & Trends

The global cold and flu supplements market size is expected to reach USD 23.11 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.6% over the forecast period. Rising health consciousness among the consumers has been driving the demand for cold and flu supplements across the world. Over the past few years, consumers have become better informed about seasonal diseases and their preventions. As a result, consumers are increasingly spending on preventive healthcare in order to limit the occurrences of cold and flu. This trend has widened the scope of cold and flu supplements across the globe.

Increasing producers’ focus on product innovation, along with shifting consumers’ preference towards natural products, has increased the opportunity for cold and flu supplements. Furthermore, rising purchasing power of the consumers is allowing them to spend more on products that help in preventing diseases and boosting immunity. This trend is expected to fuel the demand for cold and flu supplements in the upcoming years.

The vitamins and minerals product segment held the largest market share in 2019. Vitamin C, Vitamin D, and Zinc are the most consumed products among vitamins and minerals. These products help in preventing the illness and shortening its duration. Therefore, a large number of consumers have been consuming vitamins and minerals to avoid seasonal flu. The herbal extract products are projected to gain the most traction among the consumers in the upcoming years.

Asia Pacific led the market in 2019 with over 30.0% share of the global revenue. Increased spending on immunity boosting among the rising number of middle class groups in China and India has fueled the demand for the product in the region. Europe is anticipated to witness the fastest growth over the forecast period. Growing demand for natural products in the region is expected to create wide opportunities for the market.

Cold & Flu Supplements Market Report Highlights

• In terms of product, the vitamins and minerals segment dominated the market with over 35.0% share of the global revenue owing to their increased consumption among the consumers

• Herbal extract-based cold and flu supplements are expected to expand at the fastest CAGR of 6.9% from 2020 to 2027

• Asia Pacific dominated the market in 2019 with more than 30.0% share of the global revenue. Rising spending on preventive healthcare among millennials in emerging economies, including China and India, is expected to have a positive impact on the regional industry growth

• Europe is expected to register the fastest CAGR of 7.1% from 2020 to 2027 owing to growing demand for natural supplements in Germany, France, and U.K.

【レポートの目次】

Table of contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
Chapter 3. Cold & Flu Supplements Market Variables, Trends & Scope
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Sales/Retail Channel Analysis
3.3.2. Profit Margin Analysis
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.4.4. Industry Opportunities
3.5. Business Environment Analysis
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from New Entrant
3.5.1.5. Competitive Rivalry
3.6. Roadmap of Cold & Flu Supplements Market
3.7. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
4.1. Consumer Trends and Preferences
4.2. Factors Affecting Buying Decision
4.3. Consumer Product Adoption
4.4. Observations & Recommendations
Chapter 5. Cold & Flu Supplements Market: Product Estimates & Trend Analysis
5.1. Product Movement Analysis & Market Share, 2019 & 2027
5.2. Natural Molecules
5.2.1. Market estimates and forecast, 2016 – 2027 (USD Million)
5.3. Herbal Extracts
5.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
5.4. Vitamins & Minerals
5.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 6. Cold & Flu Supplements Market: Regional Estimates & Trend Analysis
6.1. Regional Movement Analysis & Market Share, 2019 & 2027
6.2. North America
6.2.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.2.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.2.3. U.S.
6.2.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.2.3.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.3. Europe
6.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.3.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.3.3. Germany
6.3.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.3.3.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.3.4. France
6.3.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.3.4.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.4. Asia Pacific
6.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.4.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.4.3. China
6.4.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.4.3.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.4.4. Japan
6.4.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.4.4.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.5. Central & South America
6.5.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.5.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.5.3. Brazil
6.5.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.5.3.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
6.6. Middle East & Africa (MEA)
6.6.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.6.2. Market estimates and forecast, by product, 2016 – 2027 (USD Million)
Chapter 7. Competitive Analysis
7.1. Key global players, recent developments & their impact on the industry
7.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
7.3. Vendor Landscape
7.3.1. Key company market share analysis, 2019
Chapter 8. Company Profiles
8.1. WAKUNAGA OF AMERICA CO., LTD.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Neurobiologix, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. The Vitamin Shoppe
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. KLAIRE LABS
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Pfizer Inc.
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. GlaxoSmithKline plc
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Nordic Naturals
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Himalaya Global Holdings Ltd.
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Nature’s Way Products, LLC (Dr. Willmar Schwabe GmbH & Co. KG)
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. FineVine
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. Flora Inc.
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. NOW Foods
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives

List of Tables

1. Cold & flu supplements - Key market driver analysis
2. Cold & flu supplements - Key market restraint analysis
3. Global natural molecules cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
4. Global herbal extracts cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
5. Global vitamins & minerals cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
6. North America cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
7. North America cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
8. U.S. cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
9. U.S. cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
10. Europe cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
11. Europe cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
12. Germany cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
13. Germany cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
14. France cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
15. France cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
16. Asia Pacific cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
17. Asia Pacific cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
18. China cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
19. China cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
20. Japan cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
21. Japan cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
22. Central & South America Cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
23. Central & South America cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
24. Brazil cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
25. Brazil cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
26. MEA cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
27. MEA cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
28. Vendor landscape

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 風邪・インフルエンザサプリメントの世界市場2020-2027:市場規模、シェア、動向分析(Cold And Flu Supplements Market Size, Share & Trends Analysis Report By Product (Natural Molecules, Herbal Extracts, Vitamins & Minerals), By Region, And Segment Forecasts, 2020 - 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆